Ignite Creation Date:
2024-05-06 @ 3:45 AM
Last Modification Date:
2024-10-26 @ 11:38 AM
Study NCT ID:
NCT02365909
Status:
TERMINATED
Last Update Posted:
2017-09-18
First Post:
2015-02-11
Brief Title:
Study Evaluating Sphenopalatine Ganglion Block SPGB for Treatment of Postdural Puncture Headache PDPH
Sponsor:
University of Arkansas
Organization:
University of Arkansas
Study Overview
Official Title:
A Prospective Randomized Double-Blind Placebo Controlled Study Evaluating Sphenopalatine Ganglion Block SPGB for Treatment of Postdural Puncture Headache PDPH
Status:
TERMINATED
Status Verified Date:
2017-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Study stopped due to difficulty recruiting patients
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PDPH
Brief Summary:
Postdural puncture headaches PDPH are a consequence of spinal and epidural anesthesia in approximately 1 of cases when performed in obstetric patients The gold standard treatment for a PDPH is currently an epidural blood patch EBP which involves placing a needle back into the epidural space of the neuraxium and then injecting 20 ml of the patients own blood through the needle and into the epidural space to form a clot over the insult in the tissue layer that causes the headaches The investigators want to test the efficacy of using a less invasive procedure called a sphenopalatine block SPGB for treatment of PDPH SPGB has been used for many years in the treatment of migraines and cluster headaches and there are several case reports of its use to successfully treat PDPH as well SPGB simply involves applying a local anesthetic to the mucosa in the back of each nostril to numb the nerves that cause the headache The investigators hope that the SPGB will reduce the number of PDPH patients that require and EBP
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None